Jennifer Saultz

14PUBLICATIONS
129CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)HaematologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 02, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

|May 20, 2026
Absolute risk trade-offs of donor age, sex, and graft source in PTCy-based transplantation.

|Apr 17, 2026
A Phase 2, Open-Label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.

|Apr 15, 2026
Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age.

|Nov 21, 2025
CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study.

Andrew S Artz, Brent Logan, Wael Saber

|Oct 03, 2025
Germline Pathogenic Variants in MUTYH Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders.

Maryam Rafati, Youjin Wang, Ashwin L Koppayi

Pageof 3

Frequent Collaborators

4 joint publications

Curtis A Lachowiez

3 joint publications

Yung-Tsi Bolon

3 joint publications

Rohtesh S Mehta

3 joint publications

Andy Kaempf